The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 14,827,684 | 16,205,119 | SH | SOLE | 16,205,119 | 0 | 0 | |||
AILERON THERAPEUTICS INC | COM NEW | 00887A204 | 1,486,534 | 830,466 | SH | SOLE | 830,466 | 0 | 0 | |||
AMERICAN WELL CORP | CL A | 03044L105 | 21,999,006 | 10,475,717 | SH | SOLE | 10,475,717 | 0 | 0 | |||
ANNEXON INC | COM | 03589W102 | 24,837,204 | 7,056,024 | SH | SOLE | 7,056,024 | 0 | 0 | |||
AADI BIOSCIENCE INC | COM | 00032Q104 | 11,154,877 | 1,630,830 | SH | SOLE | 1,630,830 | 0 | 0 | |||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 2,561,625 | 2,227,500 | SH | SOLE | 2,227,500 | 0 | 0 |